STAR and breast cancer: In pursuance of these data, we are currently generating antibodies to acetylated and deacetylated forms of StAR with K111Q, K253Q, K111R, and K253R, which could serve as molecular tools for BC screening/diagnosis and the regression of breast tumors, respectively.